RNAC — Cartesian Therapeutics Share News
0.000.00%
Last trade - 00:00- $186.98m
- $92.22m
- $2.80m
Selecta Biosciences Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Selecta Biosciences To Host Conference Call And Webcast To Discuss Q3 Results
Brief: Selecta Biosciences Reports Q2 Basic Net Income Of $0.06/Share
Brief: Selecta Biosciences Completed Enrollment In Dissolve Ii Phase 3 Clinical Trial Of SEL-212 For Treatment Of Chronic Refractory Gout
Brief: Selecta Biosciences - On June 22, Co Received Letter From Nasdaq Notifying Co It Regained Compliance With $1 Per Share Minimum Bid Price Requirement
Brief: Selecta Biosciences Announces Partnership Advancements And Clinical Trial Updates
Brief: Selecta Biosciences Inc Received Notice From Nasdaq It Is No Longer In Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
South Korea's CJ CheilJedang puts Brazil soy crusher CJ Selecta up for sale, sources say
Selecta Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Selecta Biosciences Reports First Quarter 2022 Financial Results
Selecta Biosciences Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Macy's, Conduent, Pfizer
U.S. STOCKS ON THE MOVE-CDK Global, Sprinklr, Biophytis
U.S. STOCKS ON THE MOVE-HP, JD.com, Levi Strauss
Selecta Biosciences down after stock-and-warrants offering
Brief: Selecta Biosciences Says Announces $38.7 Million Underwritten Offering
U.S. STOCKS ON THE MOVE-Halliburton, Couchbase, Newmont, Wingstop, Chevron
U.S. STOCKS ON THE MOVE-Chevron Corp, Goldman Sachs, Inari Medical
Selecta Biosciences surges as FDA lifts clinical hold on metabolic disease drug trial